Alva Health is developing a device that uses noninvasive wearables and AI/ML algorithms to monitor the onset of stroke symptoms and immediately initiate emergency calls. The wearable platform detects hemiparesis, a hallmark of stroke onset. Upon the onset of hemiparesis, the user is connected to a 24/7 call center where trained medical responders perform additional assessments and initiate 911 calls when indicated. Alva Health’s mission is to build a game-changing solution for the early detection of stroke symptoms, which will enable for the first time the automated, seamless monitoring of stroke in high-risk patients at home and away from the hospital where they are most vulnerable.
Sandra Saldana is the CEO and co-founder of Alva Health, a MedTech startup that is developing a remote monitor that detects neurological injury and stroke for people living with chronic risk of cardiovascular disease. Sandra is a scientist by training with a lifelong interest and passion to improve human health through the development, application and commercialization of innovative technologies. Sandra has completed a B.A. in biological sciences at Cornell University, a Ph.D. in cancer biology at the University of Texas MD Anderson Cancer Center and an MBA in health care management at the Yale School of Management.